发明名称 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor and use for treating diabetes complications
摘要 An isolated polynucleotide encoding human Death Domain Containing Receptor 5 (DR5) comprising a first nucleic acid that is at least 90% identical to a second nucleic acid selected from SEQ ID NO:2. The amino acid sequences for the complete polypeptide and the mature polypeptide encoded by the cDNA clone are contained in ATCC Deposit No. 97920. Also described is a vector, a host cell and a pharmaceutical composition comprising the polypeptide. Disclosed is the use of polypeptide in the preparation of a medicament for the treatment of cancer, inflammation; autoimmune disease, viral infection, and graft vs. host disease. The translated polypeptide is a member of the TNF family of receptors. It binds TNF-related apoptosis-inducing ligand (TRAIL). Methods for producing a vector containing the polynucleotide, translating the polypeptide using a host cell, using the host cell to screen for ligand binding to polypeptide, identifying agonists and antagonists of the polypeptide, the production of antibody using the polypeptide, and the diagnosis of disease or susceptibility to disease related to underexpression of the polypeptide are disclosed.
申请公布号 NZ501165(A) 申请公布日期 2001.06.29
申请号 NZ19980501165 申请日期 1998.07.02
申请人 ZENECA LIMITED 发明人 CAREY, FRANK;TUFFIN, DAVID PATRICK;CAMERON, NORMAN EUGENE;COTTER, MARY ANNE
分类号 A61K31/165;A61K31/198;A61K31/4188;A61K31/426;A61K31/502;A61K31/55;A61K38/55;A61K45/06;A61P3/10;A61P13/12;A61P25/02;A61P27/02;(IPC1-7):A61K45/06 主分类号 A61K31/165
代理机构 代理人
主权项
地址
您可能感兴趣的专利